HomeInsightsStock Comparison

Abbott India Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Abbott India Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 25, 2025

Key Highlights

  • The Latest Trading Price of Abbott India Ltd is ₹ 30818 as of 23 May 15:30.
  • The P/E Ratio of Abbott India Ltd is 0 as of March 2020 .The P/E Ratio of Novelix Pharmaceuticals Ltd is 0 as of March 2020.
  • The Market Cap of Abbott India Ltd is ₹ 0 crore as of March 2020 .The Market Cap of Novelix Pharmaceuticals Ltd is ₹ 1.57 crore as of March 2020.
  • The revenue of Abbott India Ltd for the Mar '25 is ₹ 1680 crore as compare to the Dec '24 revenue of ₹ 1686 crore. This represent the decline of -0.32% The revenue of Novelix Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 5.3 crore. This represent the decline of -100%.
  • The ebitda of Abbott India Ltd for the Mar '25 is ₹ 504.56 crore as compare to the Dec '24 ebitda of ₹ 507.84 crore. This represent the decline of -0.65% The ebitda of Novelix Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0.13 crore. This represent the decline of -100%.
  • The net profit of Abbott India Ltd changed from ₹ 290.24 crore to ₹ 367.04 crore over 8 quarters. This represents a CAGR of 12.45% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ -0.17 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Abbott India Ltd changed from 89.6 % on March 2020 to 72.53 % on March 2024 . This represents a CAGR of -4.14% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Abbott India Ltd

  • Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
  • The Company sells its products through independent distributors primarily within India.
  • It provides products and solutions across various therapeutic areas such as Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc.
  • Its global products include Brufen, Prothiaden, Thyronorm and Leptos. The company has four divisions.
  • The Primary Care division markets products in the areas of pain management and gastroenterology.

About Novelix Pharmaceuticals Ltd

  • Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
  • Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
  • They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
  • Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

Abbott India Ltd News Hub

News

Abbott India Ltd up for five straight sessions

Abbott India Ltd rose for a fifth straight session today. The stock is quoting at Rs 31190...

Read more

21 May 2025 13:00

News

Abbott India AGM scheduled

Abbott India announced that the 81th Annual General Meeting(AGM) of the company will be he...

Read more

16 May 2025 09:25

News

Board of Abbott India recommends final dividend

Abbott India announced that the Board of Directors of the Company at its meeting held on 1...

Read more

16 May 2025 09:25

News

Abbott India rises after Q4 PAT jumps 28% YoY to Rs 367 cr; declares dividend of Rs 475 /sh

Profit before tax (PBT) stood at Rs 482.71 crore in Q4 FY25, up 23.9% YoY. Total expenses ...

Read more

16 May 2025 10:58

News

Abbott India to conduct board meeting

Abbott India will hold a meeting of the Board of Directors of the Company on 15 May 2025. ...

Read more

07 May 2025 14:26

News

Abbott India appoints senior management personnel

Abbott India has appointed Anushree Kunhambu - Associate Director - New Product Introducti...

Read more

16 Apr 2025 09:38

Novelix Pharmaceuticals Ltd News Hub

News

Novelix Pharmaceuticals to convene board meeting

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27...

Read more

21 May 2025 16:50

News

Novelix Pharmaceuticals to convene EGM

Novelix Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Comp...

Read more

15 Apr 2025 10:33

News

Trimurthi to table results

Trimurthi will hold a meeting of the Board of Directors of the Company on 12 February 2025...

Read more

08 Feb 2025 10:47

News

Trimurthi to announce Quarterly Result

Trimurthi will hold a meeting of the Board of Directors of the Company on 13 November 2024...

Read more

09 Nov 2024 17:04

News

Trimurthi revises board meeting date

Trimurthi has revised the meeting of the Board of Directors which was scheduled to be held...

Read more

14 Oct 2024 10:29

News

Trimurthi to hold board meeting

Trimurthi will hold a meeting of the Board of Directors of the Company on 14 October 2024....

Read more

08 Oct 2024 10:44

SWOT Analysis Of Novelix Pharmaceuticals Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Abbott India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novelix Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Abbott India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Abbott India Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, Abbott India Ltd or Novelix Pharmaceuticals Ltd?

Market cap of Abbott India Ltd is 65,488 Cr while Market cap of Novelix Pharmaceuticals Ltd is 69 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of Abbott India Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Novelix Pharmaceuticals Ltd?

As of May 25, 2025, the Abbott India Ltd stock price is INR ₹30818.0. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹27.94.

How do dividend payouts of Abbott India Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions